The founders of BS Biotechna bring years of experience gained at global pharmaceutical companies in key positions responsible for the development of therapies at preclinical phase, I-III clinical trials, and post-marketing studies. Seven of these projects are already registered therapies, generating a revenue of over 10 billion USD annually. We have the expertise and competence to independently design and conduct preclinical and clinical research.
The scientists forming BS Biotechna team are top-tier professionals in the field of nanochemistry, biology, and medicine. They are passionate individuals with a significant track record and are renowned worldwide in their field.